Collectively, the observations of p-ASK1, p-P38, and p-JNK in Parkinson’s model systems and human tissue provide strong evidence that ASK1 is a relevant therapeutic target for Parkinsonian disorders. This evidence concerns the gene MAPK8 and Parkinsonism.